Casdin Partners Master Fund, L.P.
Insider CIK 1534265 · LAB Director, 10% owner · MXCT 10% owner · CNST 10% owner · DBTX 10% owner · ABSI Director · FULC 10% owner · WGS Director, 10% owner · VERV 10% owner · TNYA 10% owner · TSVT Director · BLFS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings Corp. | P Buy | 2026-06-05 | 2026-06-08 | 50,000 | $52.86 | $2.64M | 3,707,164 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2026-06-04 | 2026-06-08 | 150,000 | $56.44 | $8.47M | 3,657,164 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2026-05-21 | 2026-05-21 | 650,000 | $23.70 | $15.40M | 4,757,165 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2026-05-20 | 2026-05-20 | 140,000 | $43.81 | $6.13M | 3,507,164 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2026-05-20 | 2026-05-21 | 250,000 | $23.70 | $5.92M | 5,407,165 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2026-05-19 | 2026-05-20 | 185,000 | $42.60 | $7.88M | 3,367,164 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2026-05-19 | 2026-05-21 | 300,000 | $22.65 | $6.79M | 5,657,165 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2026-05-18 | 2026-05-20 | 175,000 | $42.55 | $7.45M | 3,182,164 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy deriv | 2026-05-11 | 2026-05-11 | 50,000 | — | $0 | 850,000 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy deriv | 2026-05-08 | 2026-05-11 | 300,000 | — | $0 | 800,000 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy deriv | 2026-05-07 | 2026-05-11 | 500,000 | — | $0 | 500,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-12-04 | 2025-12-04 | 150,000 | $1.45 | $217.5K | 72,100,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-12-03 | 2025-12-04 | 75,000 | $1.44 | $108.0K | 71,950,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-12-02 | 2025-12-04 | 125,000 | $1.42 | $177.5K | 71,875,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-25 | 2025-11-26 | 7,550,000 | $1.30 | $9.81M | 71,750,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-24 | 2025-11-26 | 150,000 | $1.43 | $214.5K | 64,200,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-20 | 2025-11-20 | 450,000 | $1.30 | $585.0K | 64,050,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-19 | 2025-11-20 | 350,000 | $1.28 | $448.0K | 63,600,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-18 | 2025-11-20 | 275,000 | $1.23 | $338.3K | 63,250,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-17 | 2025-11-17 | 225,000 | $1.22 | $274.5K | 62,975,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-14 | 2025-11-17 | 250,000 | $1.24 | $310.0K | 62,750,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-13 | 2025-11-17 | 450,000 | $1.20 | $540.0K | 62,500,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-12 | 2025-11-12 | 375,000 | $1.19 | $446.3K | 62,050,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-11 | 2025-11-12 | 300,000 | $1.20 | $360.0K | 61,675,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-10 | 2025-11-12 | 275,000 | $1.17 | $321.8K | 61,375,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-11-07 | 2025-11-12 | 225,000 | $1.12 | $252.0K | 61,100,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2025-10-15 | 2025-10-17 | 750,000 | $28.55 | $21.41M | 5,957,165 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-09-09 | 2025-09-11 | 100,000 | $1.29 | $129.0K | 60,875,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-09-04 | 2025-09-05 | 250,000 | $1.28 | $320.0K | 60,775,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-09-03 | 2025-09-05 | 250,000 | $1.27 | $317.5K | 60,525,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-08-26 | 2025-08-26 | 125,000 | $1.26 | $157.5K | 60,275,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-08-25 | 2025-08-26 | 200,000 | $1.24 | $248.0K | 60,150,000 | SEC↗ |
| WGS GeneDx Holdings Corp. | S Sale | 2025-08-22 | 2025-08-22 | 500,000 | $120.90 | $60.45M | 3,007,164 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-08-22 | 2025-08-26 | 200,000 | $1.26 | $252.0K | 59,950,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-08-15 | 2025-08-15 | 150,000 | $1.22 | $183.0K | 59,750,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2025-08-15 | 2025-08-21 | 500,000 | $24.40 | $12.20M | 6,707,165 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-08-14 | 2025-08-15 | 133,220 | $1.21 | $161.2K | 59,600,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-08-13 | 2025-08-15 | 75,000 | $1.31 | $98.3K | 59,466,780 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2025-08-11 | 2025-08-13 | 500,000 | $22.60 | $11.30M | 7,207,165 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | S Sale | 2025-06-10 | 2025-06-12 | 1,000,000 | $23.80 | $23.80M | 7,707,165 | SEC↗ |
| TSVT 2seventy bio, Inc. | D To issuer deriv | 2025-05-13 | 2025-05-15 | 12,050 | — | $0 | 0 | SEC↗ |
| TSVT 2seventy bio, Inc. | D To issuer deriv | 2025-05-13 | 2025-05-15 | 33,400 | — | $0 | 0 | SEC↗ |
| TSVT 2seventy bio, Inc. | U Tender | 2025-05-13 | 2025-05-15 | 2,000,000 | $5.00 | $10.00M | 0 | SEC↗ |
| TSVT 2seventy bio, Inc. | U Tender | 2025-05-13 | 2025-05-15 | 22,625 | $5.00 | $113.1K | 0 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | J Other | 2025-04-07 | 2025-04-09 | 27,994 | — | $0 | 8,735,159 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2025-02-28 | 2025-03-04 | 58,215 | $1.07 | $62.3K | 2,806,470 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2025-02-28 | 2025-03-04 | 4,820,959 | $1.07 | $5.16M | 58,846,780 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2025-02-28 | 2025-03-04 | 545,000 | $1.07 | $583.1K | 59,391,780 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2025-02-28 | 2025-03-04 | 545,000 | $1.07 | $583.1K | 0 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-27 | 2024-08-29 | 250,000 | $2.19 | $547.5K | 54,025,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-26 | 2024-08-26 | 150,000 | $2.15 | $322.5K | 53,775,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-23 | 2024-08-26 | 292,100 | $2.13 | $622.2K | 53,625,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-22 | 2024-08-26 | 307,900 | $1.96 | $603.5K | 53,333,721 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-21 | 2024-08-21 | 500,000 | $1.90 | $950.0K | 53,025,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-20 | 2024-08-21 | 500,000 | $1.87 | $935.0K | 52,525,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-19 | 2024-08-21 | 250,000 | $1.85 | $462.5K | 52,025,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-14 | 2024-08-16 | 1,200,000 | $1.59 | $1.91M | 51,775,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-13 | 2024-08-13 | 550,000 | $1.62 | $891.0K | 50,575,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-12 | 2024-08-13 | 500,000 | $1.64 | $820.0K | 50,025,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-09 | 2024-08-13 | 525,408 | $1.61 | $845.9K | 49,525,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-08 | 2024-08-09 | 569,562 | $1.64 | $934.1K | 49,000,413 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-07 | 2024-08-09 | 500,000 | $1.57 | $785.0K | 48,430,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-05 | 2024-08-06 | 200,000 | $1.58 | $316.0K | 47,930,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-08-02 | 2024-08-06 | 1,000,000 | $1.63 | $1.63M | 47,730,821 | SEC↗ |
| WGS GeneDx Holdings Corp. | J Other | 2024-08-01 | 2024-08-05 | 413,655 | $32.25 | $13.34M | 3,507,164 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2024-06-18 | 2024-06-21 | 545,000 | $2.05 | $1.12M | 545,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2024-06-18 | 2024-06-21 | 1,200,000 | $2.05 | $2.46M | 0 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2024-06-18 | 2024-06-21 | 655,000 | $2.05 | $1.34M | 46,730,821 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award deriv | 2024-06-10 | 2024-06-12 | 12,050 | $3.93 | $47.4K | 12,050 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award | 2024-06-10 | 2024-06-12 | 6,025 | — | $0 | 22,625 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-06-04 | 2024-06-05 | 30,000 | $22.52 | $675.6K | 3,093,509 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-06-03 | 2024-06-05 | 100,000 | $20.82 | $2.08M | 3,063,509 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-05-29 | 2024-05-31 | 40,000 | $21.07 | $842.8K | 2,963,509 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-05-28 | 2024-05-28 | 18,304 | $20.61 | $377.2K | 2,923,509 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-05-24 | 2024-05-28 | 144,196 | $20.12 | $2.90M | 2,905,205 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-05-23 | 2024-05-28 | 7,500 | $19.59 | $146.9K | 2,761,009 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-23 | 2024-05-28 | 100,000 | $2.60 | $260.0K | 46,075,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-22 | 2024-05-22 | 150,000 | $2.58 | $387.0K | 45,975,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-21 | 2024-05-22 | 350,000 | $2.56 | $896.0K | 45,825,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-20 | 2024-05-22 | 100,000 | $2.58 | $258.0K | 45,475,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-17 | 2024-05-17 | 352,072 | $2.56 | $901.3K | 45,375,821 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-16 | 2024-05-17 | 500,000 | $2.54 | $1.27M | 45,023,749 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-05-15 | 2024-05-17 | 500,000 | $2.57 | $1.28M | 44,523,749 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-05-13 | 2024-05-15 | 50,000 | $23.31 | $1.17M | 2,753,509 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | J Other | 2024-04-30 | 2024-05-02 | 150,000 | $17.54 | $2.63M | 0 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | J Other | 2024-04-30 | 2024-05-02 | 150,000 | $17.54 | $2.63M | 8,707,165 | SEC↗ |
| TSVT 2seventy bio, Inc. | P Buy | 2024-03-26 | 2024-03-28 | 40,000 | $5.10 | $204.0K | 2,000,000 | SEC↗ |
| TSVT 2seventy bio, Inc. | P Buy | 2024-03-25 | 2024-03-25 | 330,000 | $5.07 | $1.67M | 1,960,000 | SEC↗ |
| TSVT 2seventy bio, Inc. | P Buy | 2024-03-22 | 2024-03-25 | 147,377 | $5.12 | $754.6K | 1,630,000 | SEC↗ |
| TSVT 2seventy bio, Inc. | S Sale deriv | 2024-03-21 | 2024-03-25 | 63,151 | $4.72 | $298.1K | 536,784 | SEC↗ |
| TSVT 2seventy bio, Inc. | P Buy | 2024-03-21 | 2024-03-25 | 300,000 | $4.90 | $1.47M | 1,482,623 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | D To issuer deriv | 2024-03-18 | 2024-03-20 | 38,334 | $2.75 | $105.4K | 0 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | D To issuer deriv | 2024-03-18 | 2024-03-20 | 89,446 | $2.75 | $246.0K | 0 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2024-03-18 | 2024-03-20 | 13,939,637 | $2.75 | $38.33M | 13,939,637 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2024-03-18 | 2024-03-20 | 32,525,821 | $2.75 | $89.45M | 44,023,749 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-03-05 | 2024-03-06 | 1,403 | $2.62 | $3.7K | 11,497,928 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-03-05 | 2024-03-06 | 900 | $8.83 | $7.9K | 2,703,509 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2024-03-04 | 2024-03-06 | 250,000 | $2.57 | $642.5K | 11,496,525 | SEC↗ |
| WGS GeneDx Holdings Corp. | P Buy | 2024-03-04 | 2024-03-06 | 40,000 | $8.74 | $349.6K | 2,702,609 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2024-01-05 | 2024-01-09 | 2,744,219 | — | $0 | 2,744,219 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2024-01-05 | 2024-01-09 | 11,246,525 | — | $0 | 11,246,525 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-10-19 | 2023-10-23 | 927,165 | $11.19 | $10.37M | 8,557,165 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-08-09 | 2023-08-11 | 58,465 | $13.20 | $771.7K | 7,630,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-05-22 | 2023-05-23 | 24,973 | $21.86 | $545.9K | 150,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2023-05-19 | 2023-05-19 | 800,000 | $2.29 | $1.83M | 1,200,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-05-19 | 2023-05-23 | 50,000 | $22.55 | $1.13M | 125,027 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-05-18 | 2023-05-18 | 30,000 | $21.76 | $652.8K | 75,027 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2023-05-18 | 2023-05-19 | 150,000 | $2.16 | $324.0K | 400,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-05-17 | 2023-05-18 | 30,027 | $21.30 | $639.6K | 45,027 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2023-05-17 | 2023-05-19 | 250,000 | $1.89 | $472.5K | 250,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2023-05-16 | 2023-05-18 | 15,000 | $20.19 | $302.9K | 15,000 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2022-10-03 | 2022-10-05 | 735,786 | $6.15 | $4.53M | 10,000,000 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2022-07-01 | 2022-07-06 | 3,235,548 | $4.30 | $13.91M | 10,735,786 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award deriv | 2022-04-04 | 2022-04-06 | 127,780 | — | $0 | 127,780 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | J Other | 2021-09-01 | 2023-05-19 | 131,428 | — | $0 | 7,571,535 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | J Other | 2021-09-01 | 2021-11-03 | 126,185 | — | $0 | 7,566,292 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-04 | 2,012,880 | — | $0 | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-04 | 361,969 | — | $0 | 361,969 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-04 | 850,000 | $15.00 | $12.75M | 3,224,849 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-04 | 2,374,849 | — | $0 | 2,374,849 | SEC↗ |
| MXCT MAXCYTE, INC. | P Buy | 2021-07-30 | 2021-08-03 | 1,800,000 | $13.00 | $23.40M | 13,971,334 | SEC↗ |
| ABSI Absci Corp | C Conversion deriv | 2021-07-26 | 2021-07-28 | 1,274,431 | — | $0 | 0 | SEC↗ |
| ABSI Absci Corp | C Conversion deriv | 2021-07-26 | 2021-07-28 | 0 | — | $0 | 0 | SEC↗ |
| ABSI Absci Corp | C Conversion deriv | 2021-07-26 | 2021-07-28 | 0 | — | $0 | 0 | SEC↗ |
| ABSI Absci Corp | C Conversion | 2021-07-26 | 2021-07-28 | 4,209,573 | — | $0 | 4,209,573 | SEC↗ |
| ABSI Absci Corp | C Conversion | 2021-07-26 | 2021-07-28 | 973,260 | — | $0 | 973,260 | SEC↗ |
| ABSI Absci Corp | P Buy | 2021-07-26 | 2021-07-28 | 1,562,500 | $16.00 | $25.00M | 6,745,333 | SEC↗ |
| ABSI Absci Corp | C Conversion | 2021-07-26 | 2021-07-28 | 973,260 | — | $0 | 5,182,833 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 2,873,091 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 9,327,198 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-22 | 1,100,000 | $19.00 | $20.90M | 2,417,596 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 310,285 | — | $0 | 1,317,596 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 1,007,311 | — | $0 | 1,007,311 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 2,896,032 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 546,421 | — | $0 | 546,421 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 575,000 | $18.00 | $10.35M | 1,121,421 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2020-11-24 | 2020-11-27 | 1,600,000 | $22.50 | $36.00M | 7,440,107 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2020-07-02 | 2020-07-02 | 305,583 | $14.50 | $4.43M | 5,840,107 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2020-07-01 | 2020-07-02 | 685,000 | $14.50 | $9.93M | 5,534,524 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2020-05-22 | 2020-05-26 | 476,191 | $10.50 | $5.00M | 4,849,524 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2020-05-14 | 2020-05-18 | 1,904,762 | $10.50 | $20.00M | 4,373,333 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2019-11-20 | 2019-11-21 | 20,000 | $15.68 | $313.6K | 2,468,571 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | P Buy | 2019-11-19 | 2019-11-21 | 20,000 | $15.15 | $303.0K | 2,448,571 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion deriv | 2019-07-22 | 2019-07-22 | 3,250,000 | — | $0 | 0 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion | 2019-07-22 | 2019-07-22 | 464,285 | — | $0 | 464,285 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2019-07-22 | 2019-07-22 | 5,000 | $14.50 | $72.5K | 604,285 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2019-07-22 | 2019-07-22 | 125,000 | $16.00 | $2.00M | 589,285 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2019-07-22 | 2019-07-22 | 10,000 | $14.50 | $145.0K | 599,285 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,750,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 342,435 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,333,333 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,750,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-23 | 158,960 | — | $0 | 158,960 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-23 | 345,783 | — | $0 | 345,783 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2018-07-23 | 2018-07-23 | 266,667 | $15.00 | $4.00M | 612,450 | SEC↗ |